Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).
https://gardp.org/this-is-big/
https://gardp.org/this-is-big/
Pinned
Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis
The infection is responsible for 800,000 newborn deaths each year, but clinics in eight countries are working together to find new treatments
tinyurl.pulse.ly
📰A new @theguardian.com feature explores NeoSep1 clinical trial led by GARDP & partners to identify effective antibiotic combos for neonatal sepsis. With 800,000 newborn deaths each year, many linked to resistant infections, this work is vital to global health.
🔗https://tinyurl.pulse.ly/23ugikbwu9
🔗https://tinyurl.pulse.ly/23ugikbwu9
📰A new @theguardian.com feature explores NeoSep1 clinical trial led by GARDP & partners to identify effective antibiotic combos for neonatal sepsis. With 800,000 newborn deaths each year, many linked to resistant infections, this work is vital to global health.
🔗https://tinyurl.pulse.ly/23ugikbwu9
🔗https://tinyurl.pulse.ly/23ugikbwu9
Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis
The infection is responsible for 800,000 newborn deaths each year, but clinics in eight countries are working together to find new treatments
tinyurl.pulse.ly
November 26, 2025 at 11:03 AM
📰A new @theguardian.com feature explores NeoSep1 clinical trial led by GARDP & partners to identify effective antibiotic combos for neonatal sepsis. With 800,000 newborn deaths each year, many linked to resistant infections, this work is vital to global health.
🔗https://tinyurl.pulse.ly/23ugikbwu9
🔗https://tinyurl.pulse.ly/23ugikbwu9
📍GARDP at #WCSJ2025
Join our workshop on making AMR stories more impactful, featuring Carol Ruffell from GARDP Africa.
🗓️ 02:00 PM on 02 December
📍Pretoria, South Africa
Register: https://wcsj2025.pulse.ly/ymgayawsuk
#ScienceJournalism #AMR
Join our workshop on making AMR stories more impactful, featuring Carol Ruffell from GARDP Africa.
🗓️ 02:00 PM on 02 December
📍Pretoria, South Africa
Register: https://wcsj2025.pulse.ly/ymgayawsuk
#ScienceJournalism #AMR
November 25, 2025 at 6:59 AM
📍GARDP at #WCSJ2025
Join our workshop on making AMR stories more impactful, featuring Carol Ruffell from GARDP Africa.
🗓️ 02:00 PM on 02 December
📍Pretoria, South Africa
Register: https://wcsj2025.pulse.ly/ymgayawsuk
#ScienceJournalism #AMR
Join our workshop on making AMR stories more impactful, featuring Carol Ruffell from GARDP Africa.
🗓️ 02:00 PM on 02 December
📍Pretoria, South Africa
Register: https://wcsj2025.pulse.ly/ymgayawsuk
#ScienceJournalism #AMR
Reposted by Global Antibiotic R&D Partnership (GARDP)
To tackle rising antibiotic resistance, GARDP aims for access
A conversation with Francois Franceschi, PhD, of the Global Antibiotic Research & Development Partnership.
www.cidrap.umn.edu/a...
A conversation with Francois Franceschi, PhD, of the Global Antibiotic Research & Development Partnership.
www.cidrap.umn.edu/a...
November 24, 2025 at 5:44 PM
To tackle rising antibiotic resistance, GARDP aims for access
A conversation with Francois Franceschi, PhD, of the Global Antibiotic Research & Development Partnership.
www.cidrap.umn.edu/a...
A conversation with Francois Franceschi, PhD, of the Global Antibiotic Research & Development Partnership.
www.cidrap.umn.edu/a...
🌍 As World AMR Awareness Week 2025 concludes, GARDP’s work of developing new antibiotics, repurposing existing ones and ensuring access for all continues.
Act Now: Protect Our Present, Secure Our Future.
#WAAW2025 #AMR #ThisIsBig #Antibiotics #GARDP
Act Now: Protect Our Present, Secure Our Future.
#WAAW2025 #AMR #ThisIsBig #Antibiotics #GARDP
November 24, 2025 at 2:59 PM
🌍 As World AMR Awareness Week 2025 concludes, GARDP’s work of developing new antibiotics, repurposing existing ones and ensuring access for all continues.
Act Now: Protect Our Present, Secure Our Future.
#WAAW2025 #AMR #ThisIsBig #Antibiotics #GARDP
Act Now: Protect Our Present, Secure Our Future.
#WAAW2025 #AMR #ThisIsBig #Antibiotics #GARDP
As #USAAW25 draws to a close, we at GARDP reaffirm that tackling #AntimicrobialResistance requires all of us joining forces. The health of people, animals and our shared environment is interconnected 🧬🌍
Let’s keep the momentum going beyond the week. #WAAW2025 #CDC
Let’s keep the momentum going beyond the week. #WAAW2025 #CDC
November 24, 2025 at 12:47 PM
As #USAAW25 draws to a close, we at GARDP reaffirm that tackling #AntimicrobialResistance requires all of us joining forces. The health of people, animals and our shared environment is interconnected 🧬🌍
Let’s keep the momentum going beyond the week. #WAAW2025 #CDC
Let’s keep the momentum going beyond the week. #WAAW2025 #CDC
Proud to support the 7-7-7 Campaign by the Health Diplomacy Alliance for World AMR Awareness Week!
AMR needs coordinated action and this campaign unites voices across sectors to boost global awareness and engagement. Together, we can act now to protect our present and secure our future!
#WAAW2025
AMR needs coordinated action and this campaign unites voices across sectors to boost global awareness and engagement. Together, we can act now to protect our present and secure our future!
#WAAW2025
#AMR could cause 39M deaths by 2050 without urgent action. We need stronger investment in vaccines, diagnostics, treatments, and local manufacturing—plus cross-sector innovation, to stay ahead of resistance and ensure equitable access.
#HealthDiplomacy #7x7x7 #WAAW2025 #CSO
#HealthDiplomacy #7x7x7 #WAAW2025 #CSO
November 24, 2025 at 12:01 PM
Proud to support the 7-7-7 Campaign by the Health Diplomacy Alliance for World AMR Awareness Week!
AMR needs coordinated action and this campaign unites voices across sectors to boost global awareness and engagement. Together, we can act now to protect our present and secure our future!
#WAAW2025
AMR needs coordinated action and this campaign unites voices across sectors to boost global awareness and engagement. Together, we can act now to protect our present and secure our future!
#WAAW2025
💥 We’re at a critical tipping point. AMR deaths could rise 70% by 2050.
On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.
🔗 https://tinyurl.pulse.ly/pb09zirmta
#Thisisbig
On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.
🔗 https://tinyurl.pulse.ly/pb09zirmta
#Thisisbig
November 24, 2025 at 9:45 AM
💥 We’re at a critical tipping point. AMR deaths could rise 70% by 2050.
On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.
🔗 https://tinyurl.pulse.ly/pb09zirmta
#Thisisbig
On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.
🔗 https://tinyurl.pulse.ly/pb09zirmta
#Thisisbig
📊 2025 progress in GARDP’s DER programme
🤝Partnered with the Institute of Science Tokyo to explore protein-compound structures, aiming to develop new antibiotics for drug-resistant infections.
🔎Shared new DER research at global meetings.
🔗https://bit.pulse.ly/sp5uubtrqa
#WAAW2025
🤝Partnered with the Institute of Science Tokyo to explore protein-compound structures, aiming to develop new antibiotics for drug-resistant infections.
🔎Shared new DER research at global meetings.
🔗https://bit.pulse.ly/sp5uubtrqa
#WAAW2025
Discovery & exploratory research | GARDP
Growing drug resistance is outpacing the development of antibiotics for the most difficult-to-treat infections. Producing such antibiotics starts with the earli
bit.pulse.ly
November 23, 2025 at 3:59 PM
📊 2025 progress in GARDP’s DER programme
🤝Partnered with the Institute of Science Tokyo to explore protein-compound structures, aiming to develop new antibiotics for drug-resistant infections.
🔎Shared new DER research at global meetings.
🔗https://bit.pulse.ly/sp5uubtrqa
#WAAW2025
🤝Partnered with the Institute of Science Tokyo to explore protein-compound structures, aiming to develop new antibiotics for drug-resistant infections.
🔎Shared new DER research at global meetings.
🔗https://bit.pulse.ly/sp5uubtrqa
#WAAW2025
💥 Fewer than 3,000 scientists worldwide are working on antibiotic discovery, and progress is slowing.
We need bold action to develop new antibiotics that are both innovative and accessible to everyone, everywhere.
That’s what drives GARDP’s DER programme.
This is BIG.
#WAAW2025 #AMR #ThisIsBig
We need bold action to develop new antibiotics that are both innovative and accessible to everyone, everywhere.
That’s what drives GARDP’s DER programme.
This is BIG.
#WAAW2025 #AMR #ThisIsBig
November 23, 2025 at 12:59 PM
💥 Fewer than 3,000 scientists worldwide are working on antibiotic discovery, and progress is slowing.
We need bold action to develop new antibiotics that are both innovative and accessible to everyone, everywhere.
That’s what drives GARDP’s DER programme.
This is BIG.
#WAAW2025 #AMR #ThisIsBig
We need bold action to develop new antibiotics that are both innovative and accessible to everyone, everywhere.
That’s what drives GARDP’s DER programme.
This is BIG.
#WAAW2025 #AMR #ThisIsBig
🧬 The antibiotic pipeline is drying up, with only 90 antibiotics in development, and a small fraction addressing the most urgent threats.
In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.
#WAAW2025 #AMR #Antibiotics
In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.
#WAAW2025 #AMR #Antibiotics
November 23, 2025 at 7:02 AM
🧬 The antibiotic pipeline is drying up, with only 90 antibiotics in development, and a small fraction addressing the most urgent threats.
In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.
#WAAW2025 #AMR #Antibiotics
In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.
#WAAW2025 #AMR #Antibiotics
📊 In 2025, we:
🎓Hosted over 80 webinars with global experts
🧬Launched the 3D visualization on AntibioticDB for better data access and analysis.
📰Partnered with CMI Communications (ESCMID’s open-access journal) on selected Antimicrobial Viewpoints articles.
#WAAW2025 #AMR #Antibiotics #REVIVE
🎓Hosted over 80 webinars with global experts
🧬Launched the 3D visualization on AntibioticDB for better data access and analysis.
📰Partnered with CMI Communications (ESCMID’s open-access journal) on selected Antimicrobial Viewpoints articles.
#WAAW2025 #AMR #Antibiotics #REVIVE
November 22, 2025 at 3:59 PM
📊 In 2025, we:
🎓Hosted over 80 webinars with global experts
🧬Launched the 3D visualization on AntibioticDB for better data access and analysis.
📰Partnered with CMI Communications (ESCMID’s open-access journal) on selected Antimicrobial Viewpoints articles.
#WAAW2025 #AMR #Antibiotics #REVIVE
🎓Hosted over 80 webinars with global experts
🧬Launched the 3D visualization on AntibioticDB for better data access and analysis.
📰Partnered with CMI Communications (ESCMID’s open-access journal) on selected Antimicrobial Viewpoints articles.
#WAAW2025 #AMR #Antibiotics #REVIVE
💡 #REVIVE is one of the most comprehensive platforms in antimicrobial R&D, bringing together resources like Antimicrobial Viewpoints, webinars, conferences and AntibioticDB to support researchers worldwide.
For early-career scientists, bridging this #AMR knowledge gap is BIG. 💊
#WAAW2025
For early-career scientists, bridging this #AMR knowledge gap is BIG. 💊
#WAAW2025
November 22, 2025 at 12:59 PM
💡 AMR research faces a critical knowledge gap, fewer scientists entering the field and key lessons from antimicrobial R&D at risk of being lost.
Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 22, 2025 at 7:02 AM
💡 AMR research faces a critical knowledge gap, fewer scientists entering the field and key lessons from antimicrobial R&D at risk of being lost.
Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
📊 2025 Milestone from our Access programme
• New research: in 8 low- and middle-income countries, appropriate antibiotics were available on average in just 6.9% of cases
• WHO released new operational guidance, developed with GARDP as part of the SECURE initiative
#WAAW2025
• New research: in 8 low- and middle-income countries, appropriate antibiotics were available on average in just 6.9% of cases
• WHO released new operational guidance, developed with GARDP as part of the SECURE initiative
#WAAW2025
November 21, 2025 at 4:00 PM
📊 2025 Milestone from our Access programme
• New research: in 8 low- and middle-income countries, appropriate antibiotics were available on average in just 6.9% of cases
• WHO released new operational guidance, developed with GARDP as part of the SECURE initiative
#WAAW2025
• New research: in 8 low- and middle-income countries, appropriate antibiotics were available on average in just 6.9% of cases
• WHO released new operational guidance, developed with GARDP as part of the SECURE initiative
#WAAW2025
In many low- and middle-income countries, fewer than 1 in 15 people with multidrug-resistant infections receive the treatment they need.
🤝 GARDP is working with partners to change that.
💊 THIS IS BIG.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
🤝 GARDP is working with partners to change that.
💊 THIS IS BIG.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 21, 2025 at 1:00 PM
In many low- and middle-income countries, fewer than 1 in 15 people with multidrug-resistant infections receive the treatment they need.
🤝 GARDP is working with partners to change that.
💊 THIS IS BIG.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
🤝 GARDP is working with partners to change that.
💊 THIS IS BIG.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
Happening today as part of #WAAW2025! 🎤
Join the #AMR Poetry Slam with Swissnex India where science and art come together to spark new conversations on AMR.
🔗Register and join the poetry slam here:
https://pulse.pulse.ly/zzxa7qnmsw
Let’s use creativity to inspire action against #AMR.
Join the #AMR Poetry Slam with Swissnex India where science and art come together to spark new conversations on AMR.
🔗Register and join the poetry slam here:
https://pulse.pulse.ly/zzxa7qnmsw
Let’s use creativity to inspire action against #AMR.
November 21, 2025 at 9:42 AM
Happening today as part of #WAAW2025! 🎤
Join the #AMR Poetry Slam with Swissnex India where science and art come together to spark new conversations on AMR.
🔗Register and join the poetry slam here:
https://pulse.pulse.ly/zzxa7qnmsw
Let’s use creativity to inspire action against #AMR.
Join the #AMR Poetry Slam with Swissnex India where science and art come together to spark new conversations on AMR.
🔗Register and join the poetry slam here:
https://pulse.pulse.ly/zzxa7qnmsw
Let’s use creativity to inspire action against #AMR.
🌍More than 50 million deaths could be prevented by 2050 if effective antibiotics were made accessible. Yet in many countries, they remain unavailable or unaffordable.
In this video, Abhijit Roy explains how we are acting now to close the access gap.
#WAAW2025 #AMR #Antibiotics
In this video, Abhijit Roy explains how we are acting now to close the access gap.
#WAAW2025 #AMR #Antibiotics
November 21, 2025 at 7:01 AM
🌍More than 50 million deaths could be prevented by 2050 if effective antibiotics were made accessible. Yet in many countries, they remain unavailable or unaffordable.
In this video, Abhijit Roy explains how we are acting now to close the access gap.
#WAAW2025 #AMR #Antibiotics
In this video, Abhijit Roy explains how we are acting now to close the access gap.
#WAAW2025 #AMR #Antibiotics
GARDP joined the high-level AMR conference today hosted by the Danish AMR Alliance and partners. Peter Beyer joined a panel on solutions to AMR, highlighting our work on innovative antibiotic treatments and the responsible introduction of antibiotics to high-burden settings.
#WAAW2025 #Thisisbig
#WAAW2025 #Thisisbig
November 20, 2025 at 4:59 PM
GARDP joined the high-level AMR conference today hosted by the Danish AMR Alliance and partners. Peter Beyer joined a panel on solutions to AMR, highlighting our work on innovative antibiotic treatments and the responsible introduction of antibiotics to high-burden settings.
#WAAW2025 #Thisisbig
#WAAW2025 #Thisisbig
📊 2025 progress in GARDP’s Neonatal Sepsis programme
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
Landmark clinical trial for improving treatment options for newborns with sepsis to include nine countries | GARDP
Geneva, 12 June 2025 – A landmark clinical trial, aimed at evaluating life-saving antibiotic combination treatment options for newborns with sepsis, has been ex
bit.pulse.ly
November 20, 2025 at 4:00 PM
📊 2025 progress in GARDP’s Neonatal Sepsis programme
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.
🔗https://bit.pulse.ly/pvvkvmxmpk
#WAAW2025
💊 Newborns are often the last in line for antibiotics and it takes decades to adapt adult treatments for children.
We need to improve the global #AMR response for children and newborns! 👶
GARDP is working to develop new treatments for children, especially newborns with sepsis.
#WAAW2025
We need to improve the global #AMR response for children and newborns! 👶
GARDP is working to develop new treatments for children, especially newborns with sepsis.
#WAAW2025
November 20, 2025 at 12:59 PM
🎙️We partnered with DeFrontera on #WAAW2025 for a media science café with African journalists and beyond.
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
November 20, 2025 at 11:00 AM
🎙️We partnered with DeFrontera on #WAAW2025 for a media science café with African journalists and beyond.
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Echoing GAP-f’s message on #WorldChildrensDay 👶
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
November 20, 2025 at 10:25 AM
Echoing GAP-f’s message on #WorldChildrensDay 👶
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
🚨 The latest WHO EGASP report, released during #WAAW2025, highlights alarming increases in drug-resistant gonorrhoea.
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): gonorrhoea treatment optimization, 2024 report
The WHO EGASP report presents the latest findings from surveillance, providing quality-assured antimicrobial susceptibility testing data to inform national, regional and global treatment guidelines in participating countries. In the current report (data of 2024), 13 countries across 5 WHO regions participated, with the latest figures including demographic, clinical, and antimicrobial resistance data.
bit.pulse.ly
November 20, 2025 at 9:29 AM
🚨 The latest WHO EGASP report, released during #WAAW2025, highlights alarming increases in drug-resistant gonorrhoea.
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
November 20, 2025 at 7:03 AM
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
📊 2025 Milestone from our STIs programme
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
November 19, 2025 at 3:59 PM
📊 2025 Milestone from our STIs programme
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig